The clinical use of cisplatin (CDDP) is often associated with a severe neurotoxicity that represents the dose-limiting factor in therapy. In the past, several rat models has been accomplished to study the mechanisms involved in peripheral neuropathy induced by chronic CDDP administration and they highlight its toxic effects particularly in the dorsal root ganglia (DRG) sensory neurons that are smaller in sizes. Nevertheless, since only a limited number of cancer cell lines are able to induce the development of cancer in rat, we decided to use different murine models that allow a future combined study of the antineoplastic activity and the neurotoxic effects of CDDP. To achieve this aim, we evaluated the neurophysiological, neuropathological and morphometrical alterations induced by chronic CDDP treatment in female Balb/c, CD1 and Hola Hsd NuNu mice. Balb/c mice were treated intraperitoneally with CDDP 4mg/Kg twice a week for 4 weeks, while CD1 and Hola Hsd NuNu mice were treated with the same schedule followed by 2 weeks of follow-up. The body weight was measured once a week while at the end of the treatment we evaluated the nerve conduction velocities (NCVs) in the caudal and digital nerves and we collected DRG for the morphological and morphometrical analysis. We observed in all mice models a significant decrease in the body weight and a significant reduction in the caudal and digital NCV. This nerve functional damage was confirmed by morphological observations in DRG showing an increase in multinucleolated neurons and in nucleolar eccentricity and by the presence of nucleolar segregation. Moreover the morphometrical analysis demonstrated that CDDP affects neurons through a significant decrease in the size of somatic and nucleolar area in Balb/c mice and also in nuclear size in CD1 mice while the Nu/Nu mice showed only a significant decrease in the nuclear area. These results can confirm that the chosen schedule is able to induce peripheral neuropathy at rather different severity in the different mice strains. They could represent a useful guideline to future combined study of antineoplastic activity, neurotoxic effects of CDDP and eventually also for neuroprotection studies.

Sala, B., Carozzi, V., Chiorazzi, A., Meregalli, C., Oggioni, N., Canta, A., et al. (2012). CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS. Intervento presentato a: 11th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy.

CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS

SALA, BARBARA
Primo
;
CAROZZI, VALENTINA ALDA
Secondo
;
CHIORAZZI, ALESSIA;MEREGALLI, CRISTINA;OGGIONI, NORBERTO;CANTA, ANNALISA ROSANNA
Penultimo
;
CAVALETTI, GUIDO ANGELO
Ultimo
2012

Abstract

The clinical use of cisplatin (CDDP) is often associated with a severe neurotoxicity that represents the dose-limiting factor in therapy. In the past, several rat models has been accomplished to study the mechanisms involved in peripheral neuropathy induced by chronic CDDP administration and they highlight its toxic effects particularly in the dorsal root ganglia (DRG) sensory neurons that are smaller in sizes. Nevertheless, since only a limited number of cancer cell lines are able to induce the development of cancer in rat, we decided to use different murine models that allow a future combined study of the antineoplastic activity and the neurotoxic effects of CDDP. To achieve this aim, we evaluated the neurophysiological, neuropathological and morphometrical alterations induced by chronic CDDP treatment in female Balb/c, CD1 and Hola Hsd NuNu mice. Balb/c mice were treated intraperitoneally with CDDP 4mg/Kg twice a week for 4 weeks, while CD1 and Hola Hsd NuNu mice were treated with the same schedule followed by 2 weeks of follow-up. The body weight was measured once a week while at the end of the treatment we evaluated the nerve conduction velocities (NCVs) in the caudal and digital nerves and we collected DRG for the morphological and morphometrical analysis. We observed in all mice models a significant decrease in the body weight and a significant reduction in the caudal and digital NCV. This nerve functional damage was confirmed by morphological observations in DRG showing an increase in multinucleolated neurons and in nucleolar eccentricity and by the presence of nucleolar segregation. Moreover the morphometrical analysis demonstrated that CDDP affects neurons through a significant decrease in the size of somatic and nucleolar area in Balb/c mice and also in nuclear size in CD1 mice while the Nu/Nu mice showed only a significant decrease in the nuclear area. These results can confirm that the chosen schedule is able to induce peripheral neuropathy at rather different severity in the different mice strains. They could represent a useful guideline to future combined study of antineoplastic activity, neurotoxic effects of CDDP and eventually also for neuroprotection studies.
abstract + poster
Cisplatin, Mice Model, Peripheral Neuropathy
English
11th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy
2012
2012
open
Sala, B., Carozzi, V., Chiorazzi, A., Meregalli, C., Oggioni, N., Canta, A., et al. (2012). CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS. Intervento presentato a: 11th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy.
File in questo prodotto:
File Dimensione Formato  
Sala_01.pdf

accesso aperto

Dimensione 10.17 kB
Formato Adobe PDF
10.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/59427
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact